Table 5.
|
Baseline |
Intervention
‡
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
Total subjects |
Test group – linseed oil mix |
Control group – olive oil |
||||||||
|
(n = 38) |
(n = 46) |
(n = 30) |
||||||||
|
Cheek cell correlation |
Plasma correlation |
Cheek cell correlation |
Cheek cell correlation |
|||||||
|
Plasma |
RBC |
PBMC |
RBC |
PBMC |
Plasma |
RBC |
PBMC |
Plasma |
RBC |
PBMC |
r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | r 1 | |
SFA |
|
|
|
|
|
|
|
|
|
|
|
C16:0 |
-0.08 |
-0.1 |
0.09 |
0.80** |
0.31 |
-0.01 |
-0.2 |
-0.1 |
0.34 |
-0.17 |
0.34 |
C18:0 |
0.04 |
-0.16 |
-0.07 |
0.60** |
0.15 |
0.09 |
0.04 |
-0.14 |
0.05 |
0.22 |
-0.03 |
n-9 MUFA |
|
|
|
|
|
|
|
|
|
|
|
C18:1n-9 (OA) |
0.34* |
0.06 |
0.19 |
0.16 |
0.26 |
0.11 |
-0.05 |
-0.01 |
0.43* |
0.25 |
0.2 |
Total n-9 |
0.33* |
0.08 |
0.16 |
0.17 |
0.23 |
0.11 |
-0.05 |
0 |
0.43* |
0.29 |
0.25 |
n-6 PUFA |
|
|
|
|
|
|
|
|
|
|
|
C18:2n-6 (LA) |
-0.59 |
0.21 |
0.31 |
0.58** |
-0.13 |
-0.01 |
0.11 |
0.12 |
0.34 |
0.65** |
0.73** |
C18:3n-6 |
0.33* |
0.44** |
0.1 |
0.72** |
0.07 |
0.16 |
0.35* |
0.14 |
0 |
0.24 |
0.40* |
C20:3n-6 |
0.41** |
0.47** |
0.44** |
0.86** |
0.70** |
0.44** |
0.50** |
0.39** |
0.56** |
0.65** |
0.64** |
C20:4n-6 (AA) |
0.54** |
0.54** |
-0.21 |
0.54** |
0.09 |
0.41** |
0.41** |
-0.15 |
0.38* |
0.50** |
0.12 |
C22:5n-6 |
0.52** |
0.58** |
0.60** |
0.79** |
0.76** |
0.22 |
0.27 |
0.2 |
0.52** |
0.68** |
0.54** |
Total n-6 |
-0.22 |
-0.07 |
-0.11 |
0.22 |
-0.04 |
-0.19 |
-0.25 |
-0.05 |
0.23 |
0.44* |
0.22 |
n-3 PUFA |
|
|
|
|
|
|
|
|
|
|
|
C18:3n-3 (ALA) |
0.17 |
0.06 |
0.07 |
0.70** |
0.43** |
0.33* |
0.43** |
0.22 |
0.31 |
0.1 |
-0.17 |
C20:4n-3 (ETA) |
0.54** |
0.59** |
0.48** |
0.92** |
0.80** |
0.36** |
0.58** |
0.48** |
0.60** |
0.59** |
0.70** |
C20:5n-3 (EPA) |
0.81** |
0.82** |
0.62** |
0.84** |
0.72** |
0.69** |
0.72** |
0.54** |
0.84** |
0.83** |
0.83** |
C22:5n-3 (DPA) |
0.73** |
0.67** |
0.47** |
0.83** |
0.74** |
0.55** |
0.41** |
0.49** |
0.48** |
0.51** |
0.37* |
C22:6n-3 (DHA) |
0.68** |
0.64** |
0.59** |
0.88** |
0.80** |
0.50** |
0.59** |
0.56** |
0.61** |
0.59** |
0.64** |
Total n-3 |
0.58** |
0.61** |
0.50** |
0.85** |
0.66** |
0.45** |
0.57** |
0.55** |
0.58** |
0.64** |
0.60** |
Sum |
|
|
|
|
|
|
|
|
|
|
|
Σ SFA |
-0.24 |
-0.25 |
0.05 |
0.52 |
-0.25 |
-0.05 |
-0.24 |
0.01 |
0.27 |
0.01 |
0.09 |
Σ MUFA |
0.27 |
0.06 |
-0.06 |
0.12 |
0.14 |
0.00 |
0.05 |
-0.09 |
0.32 |
0.24 |
0.06 |
Σ PUFA | -0.21 | -0.07 | -0.2 | 0.23 | -0.10 | -0.16 | -0.12 | -0.01 | 0.17 | 0.09 | 0.11 |
‡ Results of day 7 and day 56 of each intervention combined.
1r Pearson's correlation coefficient; * P ≤ 0.05, ** P ≤ 0.01.